CTC Advisory Team

We handpick a team of experts specialized in early phase clinical development and clinical pharmacology to address the unique inquiries and requirements of each customer. The advisory team offers tailor-made guidance for an optimized trial design, spanning from the FIH trial through Phase II, with subsequent phases in mind.

The core of CTC’s advisory team consists of:

• Bengt Dahlström, founder of CTC and senior scientific advisor
• Johan Bylund, DMPK specialist and senior scientific advisor
• Sandra Kuusk, Chief Scientific Officer
• Helena Litorp, Chief Medical Officer

For each meeting, we will supplement the core team with specialists relevant for the meeting agenda. Besides our experienced in-house full-time physicians, we have access to a large pool of medical experts within various therapeutic areas. In addition, we have the possibility to invite experts from our siter companies within Center for Translational research: RegSmart Life Science AB, Toxicology Knowledge Team (TKT), Lablytica Life Science AB, MetaSafe Ab and RegFile AB.

Meeting output (examples)

• Important key elements to consider before the start of your trial
• Input on your preliminary study design
• Estimated cost (ballpark)

Before your scheduled visit, both parts will sign a CDA to enable a transparent discussion.

Book a consultation with CTC’s advisory team